Inovio Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.30

-0.06 (-4.41%)

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +1,408.5% upside

Low Target $14.26

Average Target $19.61

High Target $29.32

Current Price $1.30

Current
$1.30

Target
$19.61

$14.26 $19.61 avg $29.32

Scenario Analysis

Bear Case

$14.26

996.9%

Low target

Base Case

$19.61

+1,408.5%

Avg target

Bull Case

$29.32

+2,155.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$2.98

-56.4% from high

52-Week Low

$1.03

+26.2% from low

Target vs 52W High

$19.61

+558.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+20.5%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.2%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+178.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.1%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-88.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-23.9%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.0%